Edwards Lifesciences Corp (EW)
Quick ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cash | US$ in thousands | 1,144,000 | 769,000 | 862,800 | 1,183,200 | 1,179,100 |
Short-term investments | US$ in thousands | 500,500 | 446,300 | 604,000 | 219,400 | 337,800 |
Receivables | US$ in thousands | 775,100 | 643,000 | 582,200 | 514,600 | 543,600 |
Total current liabilities | US$ in thousands | 1,195,400 | 1,022,400 | 1,032,300 | 893,900 | 902,400 |
Quick ratio | 2.02 | 1.82 | 1.98 | 2.14 | 2.28 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($1,144,000K
+ $500,500K
+ $775,100K)
÷ $1,195,400K
= 2.02
The quick ratio of Edwards Lifesciences Corp has shown relatively stable performance over the past five years. The ratio has ranged from 2.17 to 2.60 during this period, indicating the company's ability to meet its short-term obligations with its most liquid assets. A quick ratio above 1.0 suggests that Edwards Lifesciences Corp has an ample buffer of liquid assets to cover its current liabilities, offering a favorable indication of its short-term financial health. The slight fluctuations in the quick ratio over the years may be reflective of changes in the company's liquidity position and its management of current assets and liabilities. Overall, the consistent maintenance of a quick ratio above 1.0 signifies a strong liquidity position for Edwards Lifesciences Corp, providing assurance of its ability to fulfill its short-term obligations.
Peer comparison
Dec 31, 2023